Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
|Videos|March 27, 2017
Sandra Allen-Bard on Advocating for Patients with Leukemia and Lymphoma
Author(s)Sandra Allen-Bard, MSN, ANCC, AOCNP
Sandra Allen-Bard discusses her passion for advocacy involvement with the Leukemia & Lymphoma Society.
Advertisement
Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses her involvement in advocacy groups.
Working as a nurse for patients with leukemia for over 20 years, Allen-Bard has gained a passion in seeing how life-altering this diagnosis can be. She believes that research needs to continue as there are different pathways to discover. With the
Advertisement
Related to this article
ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma
2
How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care
3
ICN 2026: APP Leadership, Cancer Pain Care, and Nurse-Led Rapid Care Models
4
FDA Approves Belzutifan Plus Lenvatinib for Advanced Clear Cell RCC
5